Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blinded Randomised Three Armed Phase II Trial of PledOx in Two Different Doses in Combination With FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Advanced Metastatic Colorectal (Stage IV) Cancer

NCT01619423 is registered in ClinicalTrials.gov with Egetis Therapeutics as lead sponsor.

NCT NCT01619423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01619423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blinded Randomised Three Armed Phase II Trial of PledOx in Two Different Doses in Combination With FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Advanced Metastatic Colorectal (Stage IV) Cancer
Lead sponsor
Egetis Therapeutics
Phase
Phase 1/2
Overall status
Completed
Start date
September 30, 2012
Completion date
December 31, 2016
Enrollment
186 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

advanced metastatic (stage iv) colorectal cancer